Nevro Corp Share Price (NYSE: NVRO)

▲

-5.84

(-100%)

Live

Last updated on April 1, 2025 at 12:00 am IST

$₹

The stock has been delisted from the stock exchange on 1 Apr 2025

Check the interactive Nevro Corp Stock chart to analyse performance

Nevro Corp Key Stats

Check Nevro Corp key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$5.84
Open	$5.84
Market Capitalization	$224.1M
Today's Volume	$750.2K
Revenue TTM	$408.5M
EBITDA	$-83.8M
Earnings Per Share (EPS)	$-3.06
Profit Margin	-27.77%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-43.29%

Global Institutional Holdings in Nevro Corp

Name
Holdings %
Name
Holdings %
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)
11.51%
Armistice Capital, LLC
9.86%
BlackRock Inc
8.05%
Vanguard Group Inc
5.44%
D. E. Shaw & Co LP
4.76%
BRAIDWELL LP
4.48%

Analyst Recommendation on Nevro Corp Stock

Rating

Trend

Hold

4%Buy

65%Hold

30%Sell

Based on 23 Wall street analysts offering stock ratings for Nevro Corp(by analysts ranked 0 to 5 stars)

Nevro Corp Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$390.3M	↑ 0.77%
Net Income	$-103.7M	↑ 110.72%
Net Profit Margin	-26.57%	↓ 13.87%

	FY20	Y/Y Change
Revenue	$362.0M	↓ 7.23%
Net Income	$-83.1M	↓ 19.89%
Net Profit Margin	-22.94%	↑ 3.63%

	FY21	Y/Y Change
Revenue	$386.9M	↑ 6.87%
Net Income	$-131.4M	↑ 58.14%
Net Profit Margin	-33.95%	↓ 11.01%

	FY22	Y/Y Change
Revenue	$406.4M	↑ 5.03%
Net Income	$3.0M	↓ 102.28%
Net Profit Margin	0.74%	↑ 34.69%

	FY23	Y/Y Change
Revenue	$425.2M	↑ 4.63%
Net Income	$-92.2M	↓ 3172.74%
Net Profit Margin	-21.69%	↓ 22.43%

	FY24	Y/Y Change
Revenue	$408.5M	↓ 3.92%
Net Income	$-113.4M	↑ 23.02%
Net Profit Margin	-27.77%	↓ 6.08%

Q3 FY23

Q4 FY23

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

	Q3 FY23	Q/Q Change
Revenue	$103.9M	↓ 4.55%
Net Income	$-23.5M	↓ 5.04%
Net Profit Margin	-22.61%	↑ 0.11%

	Q4 FY23	Q/Q Change
Revenue	$116.2M	↑ 11.86%
Net Income	$-9.0M	↓ 61.75%
Net Profit Margin	-7.73%	↑ 14.88%

	Q1 FY24	Q/Q Change
Revenue	$101.9M	↓ 12.29%
Net Income	$-25.4M	↑ 182.92%
Net Profit Margin	-24.94%	↓ 17.21%

	Q2 FY24	Q/Q Change
Revenue	$104.2M	↑ 2.22%
Net Income	$-19.6M	↓ 22.96%
Net Profit Margin	-18.79%	↑ 6.15%

	Q3 FY24	Q/Q Change
Revenue	$96.9M	↓ 6.96%
Net Income	$-15.3M	↓ 21.61%
Net Profit Margin	-15.83%	↑ 2.96%

	Q4 FY24	Q/Q Change
Revenue	$105.5M	↑ 8.91%
Net Income	$-53.1M	↑ 246.14%
Net Profit Margin	-50.32%	↓ 34.49%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$268.4M	↓ 1.82%

	FY20	Y/Y Change
Profit	$249.9M	↓ 6.87%

	FY21	Y/Y Change
Profit	$266.0M	↑ 6.46%

	FY22	Y/Y Change
Profit	$276.4M	↑ 3.88%

	FY23	Y/Y Change
Profit	$290.1M	↑ 4.95%

	FY24	Y/Y Change
Profit	$269.5M	↓ 7.08%

Q3 FY23

Q4 FY23

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

	Q3 FY23	Q/Q Change
Profit	$69.5M	↓ 6.62%

	Q4 FY23	Q/Q Change
Profit	$78.5M	↑ 12.86%

	Q1 FY24	Q/Q Change
Profit	$67.6M	↓ 13.89%

	Q2 FY24	Q/Q Change
Profit	$67.5M	↓ 0.14%

	Q3 FY24	Q/Q Change
Profit	$64.6M	↓ 4.23%

	Q4 FY24	Q/Q Change
Profit	$65.9M	↑ 2.02%

FY19

FY20

FY21

FY22

	FY19	Y/Y Change
Operating Cash Flow	$-50.2M	↑ 779.91%
Investing Cash Flow	$32.3M	↑ 402.56%
Financing Cash Flow	$32.1M	↑ 313.89%

	FY20	Y/Y Change
Operating Cash Flow	$1.2M	↓ 102.37%
Investing Cash Flow	$-369.9M	↓ 1244.04%
Financing Cash Flow	$346.9M	↑ 980.94%

	FY21	Y/Y Change
Operating Cash Flow	$-41.9M	↓ 3616.46%
Investing Cash Flow	$201.7M	↓ 154.54%
Financing Cash Flow	$-169.4M	↓ 148.83%

	FY22	Y/Y Change
Operating Cash Flow	$24.7M	↓ 158.92%
Investing Cash Flow	$64.3M	↓ 68.13%
Financing Cash Flow	$-2.5M	↓ 98.55%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-6.1M	↓ 58.01%
Investing Cash Flow	$7.3M	↓ 35.4%
Financing Cash Flow	$-1.0M	↓ 124.58%

About Nevro Corp

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS systems. It also offers Senza HFX iQ platform that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system. In addition, the company provides HFX AdaptivAI, a pain management platform that powers the HFX iQ SCS system, as well as surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is based in Redwood City, California.

Organization	Nevro Corp
Employees	1099
CEO	Mr. Kevin R. Thornal
Industry	Health Technology

Key Management of Nevro Corp

Name	Title
Mr. Kevin R. Thornal	President, CEO & Director
Mr. Roderick H. MacLeod	Senior VP & CFO
Mr. Kashif Rashid J.D.	Senior VP of Corporate Development & Chief Legal Officer
Mr. Greg Siller	Senior VP & Chief Commercial Officer
Mr. Christofer Christoforou	Senior VP & COO
Ms. Angeline C. McCabe	Vice President of Investor Relations & Corporate Communications
Ms. Shana D. Ross M.B.A.	Senior VP & Chief Human Resources Officer
Dr. David Caraway M.D., Ph.D.	Senior VP & Chief Medical Officer
Mr. Peter A. Socarras	VP, General Counsel & Corporate Secretary

Important FAQs about investing in NVRO Stock from India :

What is Nevro Corp share price today?

Nevro Corp share price today is as on April 1, 2025 at 12:00 am IST. Nevro Corp share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Nevro Corp share?

Nevro Corp share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Nevro Corp stock price today i.e. April 1, 2025 at 12:00 am IST is trending at , lower by 100% versus the 52 week high.

How to invest in Nevro Corp Stock (NVRO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Nevro Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nevro Corp Shares .

What is the minimum amount required to buy Nevro Corp Stock (NVRO) from India?

Indian investors can start investing in Nevro Corp (NVRO) shares with as little as ₹88.185 or $1 (as of September 15, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹881.85 in Nevro Corp stock (as per the Rupee-Dollar exchange rate as on September 15, 2025). Learn more about fractional shares .

What are the returns that Nevro Corp has given to Indian investors in the last 5 years?

Nevro Corp stock has given 0.0% share price returns and 19.9% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?

Discover More

Dnp Select Income Closed Fund
$10.01
+0.1%
Arvinas Inc
$7.64
-1.29%
Sap Se Adrhedged
$46.84
-0.13%
Owlet Inc
$7.07
+1.73%
Netflix, Inc.
$1,188.04
-0.03%
Alexis Practical Tactical Etf
$34.18
-0.03%
Lowe's Companies Inc.
$270.07
-0.65%
Tradr 2x Long Rgti Daily Etf
$61.76
-0.11%
Kraneshares Gh & Ei Idx Etf
$30.53
+0.79%

Explore all